BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 17, 2015
View Archived Issues
SD-208 identified as protein kinase D inhibitor with oncolytic potential
Read More
Dacomitinib assigned U.S. orphan drug status for NSCLC
Read More
MitoNEET ligand TT-01001 has beneficial effects in diabetes model
Read More
Anti-AMHR2 antibody increases the efficacy of conventional first-line chemotherapy
Read More
Altor Bioscience begins phase I/II study of ALT-803 indolent B-cell non-Hodgkin's lymphoma
Read More
ACH-3422 shows low potential for mitochondrial toxicity
Read More
MacroGenics begins phase I study of MGD-010 for autoimmune disorders
Read More
ViiV Healthcare receives approval of Triumeq
Read More
ImMucin receives E.U. orphan drug designation for multiple myeloma
Read More
Exportin-1 inhibitors display beneficial properties in multiple sclerosis model
Read More
Valeant and Salix amend merger agreement, Endo withdraws offer
Read More
New York State approves Enzo Clinical Labs' FlowScript assay to detect HPV oncogene expression
Read More
Mezzion plans phase III studies of udenafil for adolescents with a single functional ventricle
Read More
Alsonex compound gains orphan drug status in U.S. for amyotrophic lateral sclerosis
Read More
Boehringer Ingelheim patents SMAC mimetics
Read More
Johnson & Johnson and GSK invest in Dementia Discovery Fund
Read More
Bristol-Myers Squibb describes indoleamine 2,3-dioxygenase inhibitors
Read More
PTC Therapeutics discloses new Bim-1 inhibitors
Read More
Sichuan Haisco Pharmaceuticals patents SGLT2 inhibitors
Read More
Minophagen applies for approval of bexarotene for CTCL in Japan
Read More
Endo launches nasal gel testosterone replacement therapy in the U.S.
Read More
Jakavi approved in E.U. for polycythemia vera
Read More
BioInvent and ThromboGenics plan phase I/IIa studies of TB-403 in medulloblastoma
Read More
ADC Therapeutics files IND for phase I trial of ADCT-301
Read More
Kyushu University and Tokyo Medical University patent MFG-E8 compositions
Read More